ClinicalTrials.gg
RecruitingNCT07495891DURATECH-APAUpdated Nov 2, 2026

Sustainability of the Effects of an Adapted Physical Activity Program on Physical Fitness and Psycho-behavioral Factors in Patients With Chronic Diseases

An interventional study of Health and Fitness Program in Adapted Physical Activity, Smartwatches and Chronic Disease, sponsored by Hopital La Musse. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Hopital La Musse · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.
Updated Nov 2, 2026Now RecruitingFirst site in France+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
280
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to determine the extent to which different approaches to adapted physical activity coaching influence physical fitness, psycho-behavioral, and anthropometric parameters in patients with stabilized chronic conditions who have been referred to a Sport-Health Center by their physician. The trial includes four parallel groups, distinguishing between two program durations (3 months or 6 months) and the use or non-use of a smartwatch as a tool for monitoring activity. All participants complete 24 sessions of adapted physical activity (APA), in accordance with the standard practices of the La Musse Sport-Health Center, where the study is entirely conducted. However, the distribution of sessions differs by group: two sessions per week over three months or one session per week over six months. Randomization is stratified by age, sex, and baseline fitness level. Assessments are conducted at the following five time points: enrollment (T0), end of the 3-month program (T1), end of the 6-month program (T2), followed by follow-up at 12 months (T3) and 18 months (T4), to observe the durability of the effects after the supervised phase. The primary outcome measure is improvement in physical fitness and anthropometric parameters, objectively measured using tests recognized for their reliability (TDM6, Sit-to-Stand 30s, Timed Up and Go, Sit and Reach, grip strength, BMI, waist circumference). The secondary outcomes focus on changes in motivation toward health-related physical activity (EMAPS), perceived self-efficacy to engage in physical activity (ECS), and self-reported physical activity (IPAQ-SF), which will be collected regularly throughout the program, more frequently than in standard care. A total of 280 patients will be enrolled to ensure sufficient statistical power, taking into account an anticipated loss-to-follow-up rate over 18 months. Data collection and processing will be pseudonymized and conducted on the secure network of La Musse Hospital.

02

Conditions studied

  • Adapted Physical Activity
  • Smartwatches
  • Chronic Disease
  • Motivation for Physical Activity
  • Physical Fitness

Browse trials for

Keywords

  • Adapted physical activity
  • Chronic diseases
  • Smartwatch
  • Sustainability of effects
  • Motivation for physical activity
  • Self-efficacy in physical activity
  • Physical fitness
  • Longitudinal follow-up
03

In context

Chronic Disease

782 studies on the registry are indexed under Chronic Disease; 144 are open to participants now.

This study's planned enrollment of 280 is above the median of 140 across 582 interventional studies indexed under Chronic Disease.

Browse Chronic Disease studies →

Lead sponsor

Hopital La Musse is the lead sponsor of 14 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients over the age of 18
  • French-speaking patients
  • Patients with a chronic condition diagnosed by a doctor
  • Patients with a doctor's prescription for APA
  • Patients capable of understanding instructions
  • Patients enrolled in the Social Security system
  • Patients referred to Maison Sport Santé La Musse by a doctor for the first time

Non inclusion Criteria :

  • Medical to physical exertion
  • Pregnant women
  • Individuals under legal guardianship, conservatorship, or judicial protection.
  • Severe cognitive or motor impairment
  • Lack of proficiency in French
  • Patients in the acute phase requiring specialized care
  • Patients simultaneously participating in another interventional research study
  • Inability to attend sessions regularly or adhere to the schedule of evaluations.
  • Patients who have already completed a program at the Maison Sport Santé

Exclusion criteria

Exclusion Criteria:

  • Completion of fewer than 16 APA sessions (less than 70% of sessions)
  • Acute exacerbation of a chronic condition during follow-up
  • For groups without smartwatches, the use of a digital tool such as a physical activity tracker by participants would constitute an exclusion criterion
  • Completion of a patient therapeutic education program
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
280 participants (estimated)

Study arms

  • Experimental
    Group A: APA for 3 months, without a smartwatch

    APA for 3 months, without a smartwatch

    Other: Health and Fitness Program

  • Experimental
    Group B: APA for 3 months, with a smartwatch

    APA for 3 months, with a smartwatch

    Other: Health and Fitness Program

  • Experimental
    Group C: APA for 6 months, without a smartwatch

    APA for 6 months, without a smartwatch

    Other: Health and Fitness Program

  • Experimental
    Group D: APA for 6 months, with a smartwatch

    APA for 6 months, with a smartwatch

    Other: Health and Fitness Program

Interventions

  • OtherHealth and Fitness Program

    Common Practices at MSS In the standard setting of MSS La Musse, participants are referred by their primary care physician, a specialist involved in prescribing physical activity programs. Each participant undergoes an individual pre-test guided by the protocols of the National Observatory of Physical and Sports Activities (ONAPS), which assesses various parameters of physical fitness as well as certain psychological aspects (see Appendix - ONAPS protocol). These assessments serve as the basis for referral to a personalized physical activity plan (PPAP), developed jointly with a physical activity instructor. These assessments serve as the basis for referral to a personalized physical activity plan (PPAP), developed jointly with a physical activity instructor. This PPAP defines weekly goals centered on independent physical activity (gentle mobility, self-directed exercises at home), combating a sedentary lifestyle (reducing time spent resting), and participation in supervised sessions (

06

What researchers measure

Primary outcomes

  1. Improvements in physical fitness and anthropometric parameters

    Several tests will be conducted: The TDM6, which assesses cardiorespiratory fitness by measuring the distance (in meters) covered while walking at a brisk pace for six minutes; The 30-second "Sit to Stand" test, which measures quadriceps muscle endurance as well as physical capacity; The handgrip test, which assesses upper limb muscle strength; The "Sit and Reach" test, which assesses lower limb flexibility and the range of motion of the posterior chain; The "Timed Up and Go" test, which assesses overall functional mobility through a sequence of movements (standing up from a chair, walking three meters, turning around, returning, and sitting down); Body Mass Index (BMI) will be calculated using body weight (in kilograms) divided by height squared (in meters); Body weight will be measured using a calibrated electronic scale, with the participant fully clothed and barefoot; Waist circumference will be measured using a non-stretchable anthropometric tape measuring tape, placed midway bet

    Time frame: At the start of the program, 3 months after the first assessment, and then 6 months, 12 months, and 18 months

Secondary outcomes

  1. The Health-Related Physical Activity Motivation Scale

    The Health-Related Physical Activity Motivation Scale (EMAPS) measures the various forms of motivation described by self-determination theory. It consists of 18 items rated on a seven-point scale and includes six dimensions (intrinsic motivation, integrated regulation, identified regulation, introjected regulation, external regulation, and amotivation).

    Time frame: At the start of the program, and then 3 months, 6 months, 12 months, and 18 months after the first assessment

  2. The Exercise Confidence Survey (ECS)

    The Exercise Confidence Survey (ECS) is a questionnaire designed to measure perceived self-efficacy in the regular practice of physical activity. It consists of 12 items organized into two dimensions: adherence to PA, which assesses confidence in maintaining physical activity despite various obstacles (fatigue, stress, lack of support, obligations), and time management, which focuses on the ability to organize one's schedule to incorporate PA. Responses are rated on a five-point scale ranging from "I know I can't" to "I know I can."

    Time frame: At the start of the program, and then 3 months, 6 months, 12 months, and 18 months after the first assessment.

  3. The International Physical Activity Questionnaire

    The International Physical Activity Questionnaire - Short Form (IPAQ-SF, 7-day) is used to assess self-reported physical activity over the previous week. It includes questions on the frequency and duration of vigorous and moderate-intensity activities, walking, as well as time spent sitting. Responses are converted into MET-minutes per week, allowing individuals to be classified into three levels of physical activity: low, moderate, or high. An official French version is available and widely used, although psychometric validation of the short form remains limited.

    Time frame: At the start of the program, and then 3 months, 6 months, 12 months, and 18 months after the first assessment.

  4. The meCUE

    The meCUE (Modular Evaluation of Key Components of the User Experience) scale is a standardized questionnaire used to evaluate the key components of the user experience, whether instrumental (utility, usability) or non-instrumental (aesthetics, status, engagement).

    Time frame: At the start of the program, and then 3 months, 6 months, 12 months, and 18 months after the first assessment.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Oct 2028, 31 months after the start.

Of 319 non-industry interventional studies with no phase under Chronic Disease, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 33. This study's planned 31 months is above that.

Counting every sponsor, half of 329 studies reached it within 21 months; a quarter within 11 and three quarters within 33.

Chronic Disease covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 23, 2026
First posted
Mar 27, 2026
StartActual
Mar 30, 2026
Primary completionEst.
Oct 31, 2028
CompletionEst.
Dec 31, 2028
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 2, 2026
Sites
1 site added — first site in France
Show site
  • Hôpital La Musse · Saint-Sébastien-de-Morsent, France
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in France
    Show site
    • Hôpital La Musse · Saint-Sébastien-de-Morsent, France
    + 1 other change: date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07495891
Lead sponsor
Hopital La Musse
Responsible party
Sponsor
First posted
Mar 27, 2026
Start date
Mar 30, 2026
Primary completion
Oct 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Nov 2, 2026

Study contacts

Héloïse BAILLET, Dr
Contact
h.baillet@hlrs-lamusse.net
+33(0)232293047

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion